Search results :

Octreotide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: H01CB02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12
Diarrhoea very common, 3.1% - 57.9% 10.9% - 14.5% x x x
Abdominal discomfort 4.1% - 43.9% 12.7% x x x x x x
Nausea very common, 8.7% - 29.8% 10.9% x x x x x x x x x x x
Loose stools common, 3.1% - 36% 14.5% x x x x x x x x x x
Abdominal pain very common x x x x x x
Headache very common, 13.3% - 18.4% 10.9% x x x x x
Hyperglycaemia very common, 15% x x x x x x x x x x x
Pain localised very common x x x x
Flatulence very common, 0.5% - 13.2% 3.64% x x x x x x x x x x x
Injection site pain 8.2% - 9.6% x x
Constipation very common, 1% - 8.8% x x x x x x x x x x x
Dizziness common, 8.33% - 14.9% 10.9% x x x x x x x x x x x
Abdominal distension 3.33% - 7.9% x x x x x x x x x x
Fatigue 5% - 9.65% 3.64% x
Haematoma 1.67% - 9.65% 10.9% x x x
Abnormal faeces 0.5% - 6.14% x x x x x x
Anorexia common, 0-2% x x x x x x x
Dyspepsia common x x x x x
Dyspnoea common, 0-2% x x x x x x x x x x x
Rash common x x x x x x x x x x x
Hyperbilirubinaemia common x x x x x x x
Hypoglycaemia common, 0-2% x x x x x
Hypothyroidism common, 0-2% x x x x x x x x x x x
Urinary tract infection 0-6% - 6.14% x x x x x x x
Thyrotropin low common x x x x
Glucose tolerance impaired common x x x x
Biliary sludge common x x x x x x x x x x
Dysfunction thyroid common x x x x
Bradycardia common x x x x x x x
Transaminases increased common x x x x
Thyroxine free decreased common x x x x
Abdominal bloating common x x x x x x
Cold symptoms 3.33% - 6.14% x x x x x x
Flu symptoms 3.33% - 6.14% x x x x x x
Vomiting common, 2.6% - 5% 1.82% x x x x x x x x x x x
Cholelithiasis very common, 1% - 4.4% x x x x x x
Arthralgia 1.67% - 4.4% 3.64% x x x x x x
Back pain 0.5% - 4.4% x x x x x x x
Pruritus common, 0-4% - 4.4% x x x x x x x x x x x
Acne 3.33% - 4.4% x x
Steatorrhoea common, 3.6% x x x x x
Alopecia common, 1% - 3.51% x x x x x x x x x x x
Cramps of lower extremities 3.51% x x
Sinusitis 0-4% - 3.51% x x x
Pain 0.5% - 8-10% x x x x x x x x x x x
Contusion 0.5% - 4.4% 1.82% x x x x x x x
Influenza-like symptoms 0-6% x x
Arthritis 0-3% - 2.6% x x x x x x x
Tired and heavy 2.6% x x
Oedema 1-3% x x x x x x x x
Pollakiuria 1.67% - 3.51% 3.64% x x x x x x x
Cholecystitis common, 0-2% - 1.8% x x x x x x x
Eructation 0-2% - 1.8% x x x
Haemorrhoids 0-2% - 1.8% x x x x x x x
Osteoarthritis 0-2% - 1.8% x x x
Muscle twitching 0-2% - 1.8% x x x
Cramp muscle 0-3% - 0-4% x x x
Anxiety 0.5-3% x x x x x x x
Throat sore 0.5-3% x x x
Visual disturbance 0.5-3% x x x x x x x
Adrenal insufficiency 0-3% x x x x x x x
Infection 0-3% x x x
Flushing 0.5-2% x
Dry mouth 0.5-2% x x x
Insomnia 0.5-2% x x x
Dysuria 0-2% x x x
Epistaxis 0-2% x x x x x x x
Body temperature increased 0-2% x x x
Foot pain 0-2% x x x
Hypogonadism 0-2% x x x
Irritability 0-2% x x x
Breast mass 0-2% x x x
Nasal congestion 0-2% x x x
Numbness 0-2% x x x
Polyuria 0-2% x x x
Prostatitis 0-2% x x x
Tinnitus 0-2% x x x
Vaginal itching 0-2% x x x
Weight increased 0-2% x x x
Renal pain 0-2% x
Hot flush 0-2% x x x
Breast neoplasm 0-2% x
Dehydration uncommon x x x x x x
Tachycardia uncommon x x x x x x x x x
Asthenia 1-0% x x x x x x x x x x x
Gastrointestinal haemorrhage 0.5% x x x x x x
Rectal disorder 0.5% x x
Pancreatitis acute postmarketing x x x x
Anaphylactic shock postmarketing x x x x x x x x x x
Arrhythmia postmarketing x x x x x x x x x x
Cholestasis postmarketing x x x x x x
Cardiac disorder postmarketing x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x
Immune system disorder postmarketing x x x x
Intestinal obstruction postmarketing x x x x x x x x x
Jaundice postmarketing x x x x x x x x x
Jaundice cholestatic postmarketing x x x x x
Thrombocytopenia postmarketing x x
Urticaria postmarketing x x x x x x x x x
Hepatitis cholestatic postmarketing x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Hepatobiliary disease postmarketing x x x x x
Hepatitis acute postmarketing x x x x x x x
Abdominal cramps x x
Amenorrhoea x x x x
Amnesia x x x x x
Anaemia x x x x x
Hypochromic anaemia x
Appendicitis x x x x
Asthma x
Mental disorder x
Clotting x
Breast feeding x
Bronchospasm x x
Bronchitis x
Neoplasm malignant x
Candida infection x
Basal cell carcinoma x x x x
Cellulitis x x x x
Chest pain x x x x x x
Conjunctivitis x
Cough x
Acne cystic x
Cystitis x
Deafness x
Depression x x
Diabetes insipidus x x x x
Diabetes mellitus x x
Distention x
Drowsiness x x x
Ear disorder x
Endocrine disorder x x x
Extravasation x x
Liver fatty x
Fracture x
Gallbladder disorder x
Gastritis x
Gastroenteritis x
Gastrointestinal disorder x x x x x
Goitre x x x x x
Gynaecomastia x x x x
Cardiac failure congestive x x x x
Haematuria x x x x
Hepatitis x x x x x
Hernia x
Herpes simplex x
Herpes zoster x
Hyperkalaemia x
Hypertension x x x x x x
Ischaemia x x x x
Arthropathy x
Malabsorption x x x x x
Menstrual disorder x x
Metrorrhagia x
Nail disorder x
Nervous system disorder x x x x x
Nervousness x x
Neuralgia x
Neuritis x x x x
Oligomenorrhoea x x x x
Osteonecrosis x
Otitis x x x x x x x
Otitis media x
Palpitations x x x x
Pancreatitis x x x x x x x x x x x
Peptic ulcer x x x x
Petechiae x x x x
Pharyngitis x
Phlebitis x
Pituitary apoplexy x x x x
Pneumonia x x x x x
Polymenorrhoea x x x x
Pregnancy x
Prostatic disorder x
Lung nodule x x x x
Rhinitis x
Convulsion x x x x x x
Shock x x
Skin disorder x
Status asthmaticus x x x x
Ulcerative stomatitis x
Syncope x x x x x
Thrombophlebitis x x x x x x
Tremor x x x x
Upper respiratory tract infection x
Vaginal inflammation x x x x
Varicose vein x
Vertigo x x x x x
Viral infection x
Weight decreased x x x x
Wheezing x
Trauma x
Sinus bradycardia x x x x
Burning sensation x
Oedema peripheral x
Creatine phosphokinase increased x x x x
Glucose tolerance decreased x
Injection site reaction x x x
Muscular weakness x
Phosphatase alkaline increased x x x x
Dry skin x
Otorrhoea x
Malnutrition x x x x x
Stomach ache x
Malaise x
Myalgia x x x x x
Epigastric pain x x x x x x x x x
Abdominal tenderness x x x x x x x x x
Rectal tenesmus x
Discomfort x x x x x x
Intraocular pressure increased x x x x
Oily skin x
Faeces discoloured x
Galactorrhoea x x x x
Hypertension worsened x
Iron deficiency x x x x
Diabetic x x
Gallbladder polyp x x x x
Rectal haemorrhage x
Growth hormone overproduction x x
Redness x x x x x x
Anaphylactoid reaction x x x x
Vision blurred x x x x
Bell's palsy x x x x x x
Nephrolithiasis x x x x
Hyperkinesia x
Gastrointestinal symptom NOS x x
Neuropathy x
Increased activity x
Pruritus generalised x
Injection site haematoma x x x x
Breast pain female x
Stinging x x x x x x
Drug interaction x
Sweating increased x x
Sleep disorder x
Local reaction x x x
Hypertensive x x x x
Joint effusion x x x x
Hearing impaired x x x x
Paranoia x x x x
Appetite absent x
Tingling sensation x x x x x x
Somnolence x x
Loss of libido x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

OCTREOTIDE ACETATE / SANDOSTATIN LAR

Side effects:2
Source:FDA

octreotide acetate / Sandostatin

Side effects:91
Source:FDA

OCTREOTIDE

Side effects:94
Source:FDA Structured Product Label

OCTREOTIDE

Side effects:95
Source:FDA Structured Product Label

OCTREOTIDE

Side effects:95
Source:FDA Structured Product Label

Octreotide / SANDOSTATIN LAR

Side effects:59
Source:medicines.org.au

octreotide / SANDOSTATIN

Side effects:64
Source:medicines.org.au

Octreotide

Side effects:77
Source:BC Cancer

OCTREOTIDE (OCTREOTIDE ACETATE) / SANDOSTATIN LAR 30MG

Side effects:170
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label